Company news

Sedana Medical AB news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Sedana Medical announces PDUFA target action date for its New Drug Application in the U.S.

August 31, 2026

Sedana Medical announces FDA acceptance for review of its New Drug Application in the U.S.

August 19, 2026

Interim report January-June 2026

July 17, 2026

Sedana Medical submits New Drug Application to the U.S. FDA for inhaled sedation in the ICU

June 17, 2026

Sedana Medical publishes its Annual Report for 2025

April 14, 2026

Sedana Medical reports first patient treated in Early Access Program in the U.S.

March 13, 2026

Sedana Medical appoints Mikael Haag as Chief Financial Officer (CFO)

January 27, 2026

CFO Johan Spetz to leave Sedana Medical

December 19, 2025

Sedana Medical reports positive pre-NDA meeting with FDA

November 24, 2025

Calls

The 5 newest of 9 calls. Every call is listed under its year.

Decks

The 5 newest of 15 decks. Every deck is listed under its year.